Literature DB >> 3569341

Dosimetric consequences of interstitial extravasation following i.v. administration of a radiopharmaceutical.

B Shapiro, M Pillay, P H Cox.   

Abstract

The worst case radiation dose to tissue due to inadvertent intravenous injection of a radiopharmaceutical was estimated for the most commonly utilised radioisotopes. The probability of radiation injury induction was examined for the various radionuclides considering the maximal specific activity values encountered in diagnostic practice. A possible approach to the management of incidents involving extravasal activity deposition is discussed.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3569341     DOI： 10.1007/bf00620478

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  5 in total

1.  New T1-201 nuclear decay data.

Authors:  H W Nass
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

2.  Management of radiation wounds.

Authors:  J F Reinisch; C L Puckett
Journal:  Surg Clin North Am       Date:  1984-08       Impact factor: 2.741

3.  Radiation dose estimates for interstitial radiocolloid lymphoscintigraphy.

Authors:  M J Bronskill
Journal:  Semin Nucl Med       Date:  1983-01       Impact factor: 4.446

4.  Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience.

Authors:  S M Larson; J A Carrasquillo; R W McGuffin; K A Krohn; J M Ferens; L D Hill; P L Beaumier; J C Reynolds; K E Hellström; I Hellström
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

5.  What is the appropriate management of tissue extravasation by antitumor agents?

Authors:  D L Larson
Journal:  Plast Reconstr Surg       Date:  1985-03       Impact factor: 4.730
  5 in total
  7 in total

1.  Radiopharmaceuticals 1994. Nil desperandum. European Association of Nuclear Medicine Committees on Radiopharmaceuticals and Positron Emission Tomography.

Authors:  P H Cox; G J Meyer
Journal:  Eur J Nucl Med       Date:  1995-06

2.  The infiltrated radiopharmaceutical injection: dosimetric considerations.

Authors:  F P Castronovo; K A McKusick; H W Strauss
Journal:  Eur J Nucl Med       Date:  1988

3.  Subcutaneous Extravasation of Sr-89: Usefulness of Bremsstrahlung Imaging in Confirming Sr-89 Extravasation and in the Decision Making for the Choice of Treatment Strategies for Local Radiation Injuries Caused by Sr-89 Extravasation.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Kohei Kotani; Atsushi Yoshida; Hiroyuki Tsushima; Takashi Yamanaga; Daisuke Tsuruta; Susumu Shiomi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013

Review 4.  Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review.

Authors:  Jochem van der Pol; Stefan Vöö; Jan Bucerius; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-16       Impact factor: 9.236

5.  Tissue dose estimation after extravasation of 177Lu-DOTATATE.

Authors:  Perrine Tylski; Géraldine Pina-Jomir; Claire Bournaud-Salinas; Patrice Jalade
Journal:  EJNMMI Phys       Date:  2021-03-31

6.  EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Authors:  Katarina Sjögreen Gleisner; Nicolas Chouin; Pablo Minguez Gabina; Francesco Cicone; Silvano Gnesin; Caroline Stokke; Mark Konijnenberg; Marta Cremonesi; Frederik A Verburg; Peter Bernhardt; Uta Eberlein; Jonathan Gear
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-14       Impact factor: 10.057

7.  Practical Tools for Patient-specific Characterization and Dosimetry of Radiopharmaceutical Extravasation.

Authors:  Sean Wilson; Dustin Osborne; Misty Long; Josh Knowland; Darrell R Fisher
Journal:  Health Phys       Date:  2022-07-15       Impact factor: 2.922
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.